Quality and Clinical Outcomes Associated with a Gentamicin Use System Change for Managing Chorioamnionitis
- PMID: 29124501
- DOI: 10.1007/s10916-017-0856-7
Quality and Clinical Outcomes Associated with a Gentamicin Use System Change for Managing Chorioamnionitis
Abstract
Chorioamnionitis is an intra-amniotic infection with serious maternal and neonatal complications. Clinical studies suggest antibiotic administration before delivery reduces the risk of complications compared to after delivery. Our center implemented a standardized intrapartum gentamicin computerized provider order entry and dosage form dispensing system intended to improve treatment initiation efficiency in hospitalized obstetric patients. The primary objective of this retrospective study was to determine if these system changes were associated with decreased time from gentamicin ordering to administration in patients with chorioamnionitis. A secondary objective was to compare clinical outcomes before and after system changes. Classification and regression tree (CART) analyses was applied to identify key predictors. Results demonstrated a trend towards reduced time to administration in the post-implementation group. Clinical outcomes were not altered. CART analysis revealed that post-implementation assignment and length of membrane rupture predicted shorter time to gentamicin initiation. This study suggests that the specific system changes we implemented were safe and improved efficiency, but additional changes are needed to have a clinically significant impact.
Keywords: CPOE; Chorioamnionitis; Gentamicin; Obstetrics.
Similar articles
-
Daily gentamicin using ideal body weight demonstrates lower risk of postpartum endometritis and increased chance of successful outcome compared with traditional 8-hour dosing for the treatment of intrapartum chorioamnionitis.J Matern Fetal Neonatal Med. 2019 Oct;32(19):3204-3208. doi: 10.1080/14767058.2018.1460348. Epub 2018 Apr 12. J Matern Fetal Neonatal Med. 2019. PMID: 29642754
-
Evidence for the clinical management of chorioamnionitis.Semin Fetal Neonatal Med. 2012 Feb;17(1):46-50. doi: 10.1016/j.siny.2011.09.002. Epub 2011 Oct 1. Semin Fetal Neonatal Med. 2012. PMID: 21962477 Review.
-
High compared with standard gentamicin dosing for chorioamnionitis: a comparison of maternal and fetal serum drug levels.Obstet Gynecol. 2005 Mar;105(3):473-9. doi: 10.1097/01.AOG.0000151106.87930.1a. Obstet Gynecol. 2005. PMID: 15738010 Clinical Trial.
-
Daily compared with 8-hour gentamicin for the treatment of intrapartum chorioamnionitis: a randomized controlled trial.Obstet Gynecol. 2010 Feb;115(2 Pt 1):344-349. doi: 10.1097/AOG.0b013e3181cb5c0e. Obstet Gynecol. 2010. PMID: 20093909 Clinical Trial.
-
Once-daily dosing of gentamicin in obstetrics and gynecology.Clin Obstet Gynecol. 2008 Sep;51(3):498-506. doi: 10.1097/GRF.0b013e31818091cd. Clin Obstet Gynecol. 2008. PMID: 18677142 Free PMC article. Review.
Cited by
-
Antimicrobial stewardship using electronic prescribing systems in hospital settings: a scoping review of interventions and outcome measures.JAC Antimicrob Resist. 2022 Jun 28;4(3):dlac063. doi: 10.1093/jacamr/dlac063. eCollection 2022 Jun. JAC Antimicrob Resist. 2022. PMID: 35774070 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical